UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023123
Receipt number R000026460
Scientific Title Press needle for aspiration pneumonia prevention in older adults: study protocol for a randomized double-blind placebo-controlled trial
Date of disclosure of the study information 2016/07/12
Last modified on 2022/10/13 14:04:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Press needle for aspiration pneumonia prevention in older adults: study protocol for a randomized double-blind placebo-controlled trial

Acronym

Press needle for aspiration pneumonia prevention in older adults: study protocol for a randomized double-blind placebo-controlled trial

Scientific Title

Press needle for aspiration pneumonia prevention in older adults: study protocol for a randomized double-blind placebo-controlled trial

Scientific Title:Acronym

Press needle for aspiration pneumonia prevention in older adults: study protocol for a randomized double-blind placebo-controlled trial

Region

Japan


Condition

Condition

aspiration pneumonia

Classification by specialty

Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation about the aspiration pneumonitis protective effect of the press tack needle stimulation for patients with cerebrovascular disorder sequelae with a history of the aspiration pneumonitis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of occurrence of aspiration pneumonitis during study period

Key secondary outcomes

Latent time of swallowing reflex
Substance P concentrations in saliva
Mini Mental State Examination
Barthel Index
Body mass index
Examination of drawing blood
The number of fever during study period


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

PYONEX ZERO
A period of the intervention: one year
Quantity of the intervention: two places (four places in total) of ST-36 (anterior surface of lag), KI-3 (the rear of the malleolus medialis)
The number of times of the intervention: continuation pasting (we put it twice a week and change it)

Interventions/Control_2

Sham PYONEX ZERO
A period of the intervention: one year
Quantity of the intervention: two places (four places in total) of ST-36 (anterior surface of lag), KI-3 (the rear of the malleolus medialis)
The number of times of the intervention: continuation pasting (we put it twice a week and change it)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

The in and out patients in the collaborative investigation institution.
The patients who receive at-home medical care in the collaborative investigation institution.

Key exclusion criteria

The patients with the serious disease that can produce pneumonia with chronic respiratory disease, malignant tumor, chronic ischemic disease.
The patients that oral cannot take a therapeutic drug.
The patients with the allergy to metal.
The patients with severe skin reaction.
The patients whom a deglutition reflex does not occur in at initial LTSR measurement.
The patients whom aspiration pneumonitis develops in with serious case that is more than three times during the past three months.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name Kaneko
Middle name
Last name Soichiro

Organization

Tohoku University Hospital

Division name

Department of Education and Support for Regional Medicine, Department of Kampo Medicine

Zip code

9808574

Address

1-1, Seiryo-machi, Aoba ward, Sendai 980-8574, Japan

TEL

022-717-7507

Email

souichi0134@gmail.com


Public contact

Name of contact person

1st name Kaneko
Middle name
Last name Soichiro

Organization

Tohoku University Hospital

Division name

Department of Education and Support for Regional Medicine, Department of Kampo Medicine

Zip code

9808574

Address

1-1, Seiryo-machi, Aoba ward, Sendai 980-8574, Japan

TEL

022-717-7507

Homepage URL


Email

souichi0134@gmail.com


Sponsor or person

Institute

Tohoku University Hospital
Department of Education and Support for Regional Medicine, Department of Kampo Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Hospital

Address

1-1, Seiryo-machi, Aoba ward, Sendai 980-8574, Japan.

Tel

022-728-4105

Email

ec@rinri.hosp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 07 Month 19 Day

Date of IRB

2016 Year 06 Month 27 Day

Anticipated trial start date

2021 Year 02 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 11 Day

Last modified on

2022 Year 10 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026460


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name